Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prop 65

This article was originally published in The Tan Sheet

Executive Summary

California bill SB 1572, signed by Gov. Gray Davis Aug. 30, would amend Prop 65 by requiring private litigants settling any alleged violation to submit to the state AG a reporting form that includes results of the settlement, final disposition of the case. Introduced Feb. 20 by Byron Sher (D-Stanford), SB 1572 moved through the legislature without substantive amendment. Measure will supplement added controls on Prop 65 cases recently established by Sher's SB 471, enacted in October 2001. State is in the process of implementing law, which requires private litigants to produce "certificate of merit" demonstrating good cause for seeking Prop 65 warnings (1"The Tan Sheet" May 13, 2002, p. 14)...

You may also be interested in...



Prop 65 Certificate Of Merit Exposure Specificity Urged By CHPA

Certificates of merit filed with private enforcement actions under California's Proposition 65 should include specific details about the alleged toxic exposures, the Consumer Healthcare Products Association says

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel